EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

The Placebo Effect in Psychosis: Why It Matters and How to Measure It

Emily J Hird, Kelly Diederen, Stefan Leucht, Karin B Jensen, Philip McGuire

Biological Psychiatry Global Open Science · 2023-10 · 3 (4) · 605-613

DOI: 10.1016/j.bpsgos.2023.02.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biological Psychiatry Global Open Science, 2023-10. Verfasst von Emily J Hird und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, England. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Riksbankens Jubileumsfond.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psychosis is characterized by unusual percepts and beliefs in the form of hallucinations and delusions. Antipsychotic medication, the primary treatment for psychosis, is often ineffective and accompanied by severe side effects, but research has not identified an effective alternative in several decades. One reason that clinical trials fail is that patients with psychosis tend to show a significant therapeutic response to inert control treatments, known as the placebo effect, which makes it difficult to distinguish drug effects from placebo effects. Conversely, in clinical practice, a strong placebo effect may be useful because it could enhance the overall treatment response. Identifying factors that predict large placebo effects could improve the future outlook of psychosis treatment. Biomarkers of the placebo effect have already been suggested in pain and depression, but not in psychosis. Quantifying markers of the placebo effect would have the potential to predict placebo effects in psychosis clinical trials. Furthermore, the placebo effect and psychosis may represent a shared neurocognitive mechanism in which prior beliefs are weighted against new sensory information to make inferences about reality. Examining this overlap could reveal new insights into the mechanisms underlying psychosis and indicate novel treatment targets. We provide a narrative review of the importance of the placebo effect in psychosis and propose a novel method to assess it.

Schlagwörter

Stichwörter der Autor:innen

CognitionImagingMachine learningPlacebo effectPredictionSchizophrenia

Autor:innen und Institutionen

  • Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, England.
  • Department of Psychiatry and Psychotherapy, Technical University of Munich, Munich, Germany.
  • Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.

Förderung

  • Riksbankens Jubileumsfond

Zitieren

APA

Hird, E. J., Diederen, K., Leucht, S., Jensen, K. B., & McGuire, P. (2023). The Placebo Effect in Psychosis: Why It Matters and How to Measure It. Biological Psychiatry Global Open Science, 3(4), 605-613. https://doi.org/10.1016/j.bpsgos.2023.02.008

Vancouver

Hird EJ, Diederen K, Leucht S, Jensen KB, McGuire P. The Placebo Effect in Psychosis: Why It Matters and How to Measure It. Biological Psychiatry Global Open Science. 2023;3(4):605-613. doi:10.1016/j.bpsgos.2023.02.008

BibTeX
@article{Hird2023,
  author = {Hird, Emily J and Diederen, Kelly and Leucht, Stefan and Jensen, Karin B and McGuire, Philip},
  title = {The Placebo Effect in Psychosis: Why It Matters and How to Measure It},
  journal = {Biological Psychiatry Global Open Science},
  year = {2023},
  volume = {3},
  number = {4},
  pages = {605--613},
  doi = {10.1016/j.bpsgos.2023.02.008}
}
Kostenlos starten →